Teresa Tarragó is a board member at Accure Therapeutics and a strategy and business development advisor at ONIRIA. Teresa has also worked at Exheus, The Collider, and Vall d´Hebron Institute of Oncology (VHIO). Teresa has published 22 peer review journals and 2 book chapters and filed 2 patents. Teresa has earned the Red Emprendia Prize for Best Biotechnology Project of Iberoamerica, Santander Bank, Iberoamerica University to Business Competition, 2012. Teresa was named a finalist in BIOCHEM BP Competition, Frankfurt, Germany, 2012. Teresa received the Biotechnology Young Entrepreneur Award, SEBBM, 2011.
Teresa Tarragó started their educational career with a Bachelor of Science in Biochemistry from Universitat de Barcelona. Teresa then went on to earn their Doctor of Philosophy in Molecular Biology from the same school. After working for a few years, they decided to return to school to earn their MBA from Esade. Teresa has also completed executive programs at IESE Business School and HEC Paris. Most recently, they completed the Ignite program at the University of Cambridge.